KZA kazia therapeutics limited

News: KZA Kazia Enters Clinical Collaboration With Cornell University

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    June 15 (Reuters) - Kazia Therapeutics Ltd (KZA) :

    • KAZIA ENTERS CLINICAL COLLABORATION WITH CORNELL UNIVERSITY FOR PHASE II CLINICAL STUDY USING PAXALISIB IN COMBINATION WITH KETOGENIC DIET FOR GLIOBLASTOMA
    • KAZIA THERAPEUTICS LTD - KAZIA WILL PROVIDE SUPPORT INCLUDING STUDY DRUG AND A FINANCIAL GRANT
    • KAZIA - RECRUITMENT TO STUDY IS EXPECTED TO COMMENCE BY END OF CY2021, SUBJECT TO APPROVAL BY INSTITUTIONAL REVIEW BOARDS, FDA, OTHER AUTHORITIES
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.